Agilent Technologies Inc (NYSE:A) was the recipient of some unusual options trading activity on Monday. Stock traders acquired 77,934 put options on the stock. This is an increase of 1,169% compared to the average volume of 6,142 put options.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 21,850 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the transaction, the chief executive officer now owns 324,687 shares in the company, valued at approximately $24,351,525. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the transaction, the chief executive officer now owns 327,882 shares in the company, valued at approximately $22,951,740. The disclosure for this sale can be found here. Over the last three months, insiders sold 219,991 shares of company stock worth $15,468,795.

Hedge funds have recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of Agilent Technologies by 9.9% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock valued at $64,086,000 after acquiring an additional 90,317 shares during the last quarter. Timber Hill LLC bought a new position in shares of Agilent Technologies during the third quarter valued at $1,672,000. Colony Group LLC bought a new position in shares of Agilent Technologies during the second quarter valued at $260,000. Fisher Asset Management LLC bought a new position in shares of Agilent Technologies during the third quarter valued at $609,000. Finally, Chevy Chase Trust Holdings Inc. raised its stake in shares of Agilent Technologies by 0.9% during the third quarter. Chevy Chase Trust Holdings Inc. now owns 282,115 shares of the medical research company’s stock valued at $18,112,000 after acquiring an additional 2,599 shares during the last quarter.

Several analysts recently issued reports on the stock. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a research report on Tuesday, October 31st. Barclays reiterated a “buy” rating and set a $74.00 price target on shares of Agilent Technologies in a research report on Monday, January 8th. Robert W. Baird reiterated a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Friday, October 20th. Evercore ISI assumed coverage on shares of Agilent Technologies in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price target on the stock. Finally, ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Six equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $69.25.

Shares of Agilent Technologies (NYSE A) traded up $1.36 during trading hours on Wednesday, reaching $69.70. 3,628,392 shares of the company traded hands, compared to its average volume of 2,254,135. The company has a market cap of $22,410.00, a P/E ratio of 33.19, a price-to-earnings-growth ratio of 2.07 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies has a fifty-two week low of $50.56 and a fifty-two week high of $75.00.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.59 earnings per share. equities analysts predict that Agilent Technologies will post 2.58 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Agilent Technologies Sees Unusually High Options Volume (A)” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://theolympiareport.com/2018/02/14/agilent-technologies-sees-unusually-high-options-volume-a.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.